Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 203

1.

Sodium cromoglycate alone and in combination with montelukast on the airway response to mannitol in asthmatic subjects.

Anderson SD, Brannan JD, Perry CP, Caillaud C, Seale JP.

J Asthma. 2010 May;47(4):429-33. doi: 10.3109/02770900903584043.

PMID:
20528598
2.

Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.

Rorke S, Jennison S, Jeffs JA, Sampson AP, Arshad H, Holgate ST.

Thorax. 2002 Apr;57(4):323-7.

3.

Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol.

Brannan JD, Anderson SD, Gomes K, King GG, Chan HK, Seale JP.

Am J Respir Crit Care Med. 2001 May;163(6):1420-5.

PMID:
11371412
4.

Exercise-induced bronchoconstriction in children: montelukast attenuates the immediate-phase and late-phase responses.

Melo RE, Solé D, Naspitz CK.

J Allergy Clin Immunol. 2003 Feb;111(2):301-7.

PMID:
12589349
5.

Exercise-induced wheeze: Fraction of exhaled nitric oxide-directed management.

Cowan DC, Hewitt RS, Cowan JO, Palmay R, Williamson A, Lucas SJ, Murrell CJ, Thomas KN, Taylor DR.

Respirology. 2010 May;15(4):683-90. doi: 10.1111/j.1440-1843.2010.01740.x. Epub 2010 Mar 16.

PMID:
20337988
6.

Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients.

Dockhorn RJ, Baumgartner RA, Leff JA, Noonan M, Vandormael K, Stricker W, Weinland DE, Reiss TF.

Thorax. 2000 Apr;55(4):260-5.

7.

Prolonged effect of montelukast in asthmatic children with exercise-induced bronchoconstriction.

Kim JH, Lee SY, Kim HB, Kim BS, Shim JY, Hong TJ, Hong SJ.

Pediatr Pulmonol. 2005 Feb;39(2):162-6.

PMID:
15633203
8.

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.

Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L, Dockhorn R, Kundu S, Zhang J, Seidenberg BC, Reiss TF.

N Engl J Med. 1998 Jul 16;339(3):147-52.

9.
10.

[The effect of montelukast, a leukotriene antagonist, on improvement of exercise-induced bronchoconstriction].

Sun TY, Guo YF, Xu XM, Zhang HS, Hou J, Ke HX, Li YM, Fang BM, Ming SH.

Zhonghua Jie He He Hu Xi Za Zhi. 2005 Feb;28(2):83-7. Chinese.

PMID:
15854387
11.

[Preventive monotherapy with montelukast versus DNCG in children with mild asthma. Results of and exploratory pilot study].

Liebke C, Sommerfeld C, Wahn U, Niggemann B.

Pneumologie. 2001 May;55(5):231-7. German.

PMID:
11449608
12.

Add-on montelukast to inhaled corticosteroids protects against excessive airway narrowing.

Ulrik CS, Diamant Z.

Clin Exp Allergy. 2010 Apr;40(4):576-81. doi: 10.1111/j.1365-2222.2010.03447.x. Epub 2010 Feb 1.

PMID:
20128823
13.

Effects of montelukast on airway narrowing from eucapnic voluntary hyperventilation and cold air exercise.

Rundell KW, Spiering BA, Baumann JM, Evans TM.

Br J Sports Med. 2005 Apr;39(4):232-6.

14.

Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma.

Kemp JP, Dockhorn RJ, Shapiro GG, Nguyen HH, Reiss TF, Seidenberg BC, Knorr B.

J Pediatr. 1998 Sep;133(3):424-8.

PMID:
9738728
15.

Protection against exercise-induced bronchoconstriction two hours after a single oral dose of montelukast.

Philip G, Villarán C, Pearlman DS, Loeys T, Dass SB, Reiss TF.

J Asthma. 2007 Apr;44(3):213-7.

PMID:
17454341
16.

Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.

O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.

Pharmacoeconomics. 2004;22(12):815-25.

PMID:
15294013
17.

An open-label study examining the effect of pharmacological treatment on mannitol- and exercise-induced airway hyperresponsiveness in asthmatic children and adolescents with exercise-induced bronchoconstriction.

Schafroth Török S, Mueller T, Miedinger D, Jochmann A, Zellweger LJ, Sauter S, Goll A, Chhajed PN, Taegtmeyer AB, Knöpfli B, Leuppi JD.

BMC Pediatr. 2014 Aug 2;14:196. doi: 10.1186/1471-2431-14-196.

18.
19.

Spotlight on montelukast in asthma in children 2 to 14 years of age.

Muijsers RB, Noble S.

Am J Respir Med. 2002;1(3):225-8. Review.

PMID:
14720060
20.

Bronchoconstriction provoked by exercise in a high-particulate-matter environment is attenuated by montelukast.

Rundell KW, Spiering BA, Baumann JM, Evans TM.

Inhal Toxicol. 2005 Feb;17(2):99-105.

PMID:
15764487

Supplemental Content

Support Center